CHO Cell Line Development: Boost Clonal Outgrowth & Reduce Variability – Webinar

The biomanufacturing of protein, cellular and gene therapies relies heavily on the generation of stable, high-performing cell lines. A new webinar, hosted by Xtalks, will address a critical bottleneck in this process: achieving robust and reproducible single-cell outgrowth during clonal cell line development. The webinar, scheduled for Tuesday, March 24, 2026, will explore the challenges of single-cell cloning, particularly the low viability and potential delays caused by inadequate nutritional support for cells as they begin to proliferate.

This free webinar aims to provide insights into strategies for supporting single-cell survival and early clonal expansion, focusing on the impact of cell culture supplements on CHO (Chinese Hamster Ovary) cell clonal outgrowth efficiency. CHO cells are widely used in biopharmaceutical production due to their ability to perform complex post-translational modifications, making them ideal for manufacturing therapeutic proteins. Optimizing the cloning process is therefore essential for efficient biomanufacturing.

Understanding the Challenges of Single-Cell Cloning

Single-cell cloning, the process of isolating a single cell and allowing it to proliferate into a clonal cell line, is a fundamental step in cell line development. However, it’s not without its hurdles. The initial stages of clonal outgrowth are particularly vulnerable, as single cells require a specific nutritional environment to survive and begin dividing. Variability in these early stages can lead to inconsistencies between different cell pools and cloning campaigns, ultimately impacting the quality and productivity of the final cell line. The webinar will delve into common sources of this variability and present approaches to minimize pool-to-pool inconsistency.

Adam Causer, Global Product Manager at Nova Biomedical, and Dorothee Düsterhöft, Associated Scientist at UGA Biopharma, will lead the discussion. They will draw upon data from multiple independent single-cell cloning studies to illustrate how optimized supplementation strategies can significantly improve early clonal outgrowth. Nova Biomedical specializes in cell culture technology, while UGA Biopharma focuses on cell line development, bringing complementary expertise to the webinar.

The Role of Cell Culture Supplements

Cell culture supplements provide essential nutrients and growth factors that support cell viability and proliferation. The webinar will focus on how carefully selected supplements can address the specific needs of single cells during the critical early stages of cloning. This is particularly critical as cells transition from a protected environment within a population to the stress of isolation and the demand to establish a new colony.

The speakers will discuss how workflow choices influence both the performance and consistency of single-cell cloning. This includes considerations for transitioning workflows toward chemically defined, regulator-ready environments. Chemically defined media, where all components are precisely known, are increasingly favored in biomanufacturing to ensure product quality and regulatory compliance. However, adapting cloning workflows to these environments requires careful optimization of supplementation strategies.

Reproducibility and Scalability in CHO Cell Line Development

A key focus of the webinar will be on achieving reproducible single-cell outgrowth in CHO cell line development platforms. Reproducibility is crucial for ensuring that the characteristics of a cell line remain consistent over time and across different production batches. The speakers will share insights into what drives this reproducibility and how to move beyond incremental improvements toward more reliable and scalable workflows.

The webinar will also address the importance of considering the entire workflow, from initial cell isolation to clonal expansion and characterization. This holistic approach is essential for identifying potential bottlenecks and optimizing each step to maximize the efficiency and consistency of the cell line development process. The CellCelector Flex platform, mentioned in related resources, is an example of technology designed to improve the precision and throughput of single-cell cloning.

Moving Towards Future-Ready Workflows

The biopharmaceutical industry is constantly evolving, with increasing demands for higher productivity, improved product quality, and faster development timelines. The webinar will explore how to evolve single-cell cloning strategies to meet these challenges. This includes adopting more automated and standardized workflows, leveraging advanced analytical tools, and implementing robust quality control measures.

Attendees will gain practical guidance on evaluating and implementing new technologies and strategies to optimize their cell line development processes. The speakers will emphasize the importance of a data-driven approach, using data from multiple studies to inform decision-making and ensure that improvements are sustainable and scalable.

Registering for the Webinar and Further Information

The webinar, “Evaluating the Impact of Cell Culture Supplements on CHO Clonal Outgrowth Efficiency,” will be held on Tuesday, March 24, 2026, at 8am EDT (1pm CET/EU-Central). Registration is free and available through the Xtalks website.

Xtalks is a community platform dedicated to providing professionals in the life sciences with trusted knowledge and collaborative insights. Visit www.xtalks.com to learn more about their webinars, podcasts, and other resources. For inquiries, Vera Kovacevic can be contacted at [email protected].

What to expect after the webinar: The insights shared during the webinar will likely prompt further investigation into optimized supplementation strategies within individual cell line development programs. Attendees can anticipate a renewed focus on data collection and analysis to refine their cloning workflows and improve the consistency and reliability of their CHO cell lines. Continued collaboration and knowledge sharing within the biopharmaceutical community will be essential for driving further advancements in this critical area of biomanufacturing.